Neurocrine Biosciences (NBIX) Revenue: 2009-2020
Historic Revenue for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to $1.0 billion.
- Neurocrine Biosciences' Revenue rose 14.51% to $296.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 billion, marking a year-over-year increase of 2.62%. This contributed to the annual value of $1.0 billion for FY2020, which is 32.71% up from last year.
- As of FY2020, Neurocrine Biosciences' Revenue stood at $1.0 billion, which was up 32.71% from $788.1 million recorded in FY2019.
- Neurocrine Biosciences' 5-year Revenue high stood at $1.0 billion for FY2020, and its period low was $15.0 million during FY2016.
- Moreover, its 3-year median value for Revenue was $788.1 million (2019), whereas its average is $761.7 million.
- As far as peak fluctuations go, Neurocrine Biosciences' Revenue decreased by 24.24% in 2016, and later skyrocketed by 2,908.00% in 2018.
- Over the past 5 years, Neurocrine Biosciences' Revenue (Yearly) stood at $15.0 million in 2016, then remained steady at $15.0 million in 2017, then soared by 2,908.00% to $451.2 million in 2018, then skyrocketed by 74.67% to $788.1 million in 2019, then surged by 32.71% to $1.0 billion in 2020.